Global Biomarkers Market Size is Expected to Reach USD 30.6 Billion With a CAGR of 16% During 2013 - 2022 Forecast Period - Valuates Reports™HomeMailNewsFinanceSportsEntertainmentSearchMobileMore...YAHOO_FINANCESearchSign inMailSign in to view your mailFinance HomeWatchlistsMy PortfolioScreenersPremiumMarketsIndustriesPersonal FinanceVideosNewsTechU.S. Markets closedS&P 5002,978.76-137.63(-4.42%)Dow 3025,766.64-1,190.95(-4.42%)Nasdaq8,566.48-414.29(-4.61%)Global Biomarkers Market Size is Expected to Reach USD 30.6 Billion With a CAGR of 16% During 2013 - 2022 Forecast Period - Valuates Reports™PR NewswireJanuary 3, 2020ReblogShareTweetShareBANGALORE, India, Jan. 3, 2020 /PRNewswire/ --GLOBAL BIOMARKER MARKET OVERVIEW:Technological advances in biomarker-based diagnostics technology are likely to contribute to market expansion. Further, increase in global disease burden, especially with high prevalence of cancer, diabetes, cardiovascular disorders, and other chronic diseases supported by unhealthy diet, lack of exercise, and a sedentary lifestyle, was a major driving force in market growth.Valuates_Reports_LogoMoreBiomarkers for diagnosis are minimal and non-invasive devices. Biomarkers are used in imaging technology to provide accurate images of oncology tumors and other issues as well as to reduce the risk of radiation exposure by CT scanning and MRI scanning during imaging.View Full Report: https://reports.valuates.com/market-reports/ALLI-Manu-1H4/biomarkers-marketBIOMARKER MARKET SEGMENT REVIEW:Diagnostic biomarkers are divided into two major types which include biomarkers of exposure and biomarkers of disease. Biomarkers of exposure are an emerging technology of identifying the hazardous chemical level in individual body. Biomarkers of disease are used in identification of disease condition and also help in validation of clinical trials for novel drugs.Diagnostic biomarker market is growing with the development of technologies in clinical laboratory tests, imaging exams, and in recent years biomarker tests are impacting the clinical management of patients.Inquire for Sample; https://reports.valuates.com/request/sample/ALLI-Manu-1H4/Biomarkers_MarketREGIONAL BIOMARKER MARKET TRENDS:Heart diseases are the world's leading cause of death, and Asia Pacific has a major share of coronary heart disease in particular. According to data published by the Ministry of Health in China, cardiovascular disease affects around 203 million people and this number is expected to rise by 73 percent in 2030.It is expected that the biomarker market will expand its presence; as pharmaceutical companies invest more in drug discovery and production in Asian countries as the health care process market is more in the Asia Pacific region.Inquire for Regional: https://reports.valuates.com/request/regional/ALLI-Manu-1H4/Biomarkers_MarketKEY BENEFITS OF THE REPORTThe report identifies top investment pockets and offers an analysis of top winning strategies for diagnostic biomarker industry The report offers an assessment and ranking of the factors that favor the biomarkers market growth and those factors which act as a hindrance for the growth of the market The report analyses the various strategies adopted by some of the key companies in the industry The report tracks and analyses key innovations and patents for biomarkers in the last five yearsBuy Now: https://reports.valuates.com/api/directpaytoken?rcode=ALLI-Manu-1H4BIOMARKERS MARKET KEY SEGMENTSDiagnostic Biomarkers Market is segmented as follows:BIOMARKERS MARKET BY TYPESBiomarker of Exposure Biomarker of DiseasesBIOMARKERS MARKET BY APPLICATIONSRisk Assessment Development of Molecular Diagnostic Disease Diagnosis Drug Discovery and Development Drug Formulation Forensic Application Others (DNA Fingerprinting and Others)BIOMARKERS MARKET BY SERVICESSample Preparation Assay Development Biomarker Validation and Testing Other ServicesBIOMARKERS MARKET BY GEOGRAPHYNorth America Europe Asia-Pacific Row (Rest of World)KEY AUDIENCESPharmaceutical companies Government & Private research institutes Academic institutes Medical device manufacturing companiesREPORTS RELATED TO THE SUBSET OF BIOMARKERS MARKET:GLOBAL NEUROLOGICAL BIOMARKERS MARKETNeurological disorders affect a large percentage of the global population and are considered a major cause of global impairment.The global Neurological Biomarkers market is valued at 4710 million US$ in 2018 and will reach 8950 million US$ by the end of 2025, growing at a CAGR of 9.6% during 2019-2025.View Full Report: https://reports.valuates.com/market-reports/QYRE-Auto-515/global-neurological-biomarkers-marketGLOBAL CANCER BIOMARKERS MARKETIncreasing instances of cancer globally and higher acceptance for treatment in developing economies is one of the factors largely attributing to the growth of the Global Cancer Biomarkers Market.The Global Cancer Biomarkers Market is expected to grow from USD 12635.68 Millions in 2018 to USD 26835.68 Millions by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 11.36%.Story continuesView Full Report: https://reports.valuates.com/market-reports/360I-Auto-2X22/global-cancer-biomarkers-marketKey players in the market are putting regressive efforts to provide innovative offerings and benchmark strategies in the Global Cancer Biomarkers Market.GLOBAL GENOMICS BIOMARKERS MARKETThe expression, function, and regulation of a gene can be determined by a genomic biomarker. These have one or more deoxyribonucleic acid (DNA) and/or ribonucleic acid (RNA) properties.View Full Report: https://reports.valuates.com/market-reports/QYRE-Othe-4V164/global-genomics-biomarkersGrowing instances of low-cost clinical trials in developing countries will boost the growth prospects for the global genomics biomarker market till the end of 2021. GLOBAL PREDICTIVE BIOMARKERS MARKETPredictive biomarkers help optimize therapy decisions by providing information on the likelihood of a chemical reaction. Due to the increase in cancer prevalence rate, the predictive biomarkers market is expected to experience rapid growth over the forecast period.View Full Report: https://reports.valuates.com/market-reports/QYRE-Othe-3K170/predictive-biomarkers-marketGLOBAL CARDIAC BIOMARKERS MARKET:Cardiac biomarkers are biological parameters that can be quantified. These are commonly used to test cardiovascular disease severity.View Full Report: https://reports.valuates.com/market-reports/ALLI-Auto-2M34/cardiac-biomarkers-marketThis report studies the size (value and volume) of the Cardiac Biomarkers market by players, countries, product types and end industries, with 2014-2018 historical data and 2019-2025 forecast data.Further, this report also studies the global competitive landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.ABOUT US: Valuates offers in-depth market insights into various industries. Our extensive report repository is constantly updated to meet your changing industry analysis needs. Our team of market analyst can help you select the best report covering your industry. We understand your niche region-specific requirements and that's why we offer customization of reports. With our customization in place, you can request for any particular information from a report that meets your market analysis needs.Valuates is curating premium Market Research Reports from the leading publishers around the globe. We will help you map your information needs to our report repository of Market research reports and guide you through your purchasing decision. We are based out of Silicon Valley of India (Bengaluru) and provide 24/6 online and offline support to all our customers and just a phone call away.CONTACT US:Valuates Reportssales@valuates.com For U.S. Toll Free Call  +1-(315)-215-3225For IST Call  +91-8040957137WhatsApp : +91-9945648335Website: https://reports.valuates.comCisionMoreView original content:http://www.prnewswire.com/news-releases/global-biomarkers-market-size-is-expected-to-reach-usd-30-6-billion-with-a-cagr-of-16-during-2013---2022-forecast-period---valuates-reports-300980403.htmlSOURCE Valuates ReportsReblogShareTweetShareRecently ViewedYour list is empty.What to Read NextHow investors are using ‘alternative’ data to track China’s recovery from coronaviruMarketWatchBank of Canada to stay put for now, but 2020 rate cut in play: Reuters pollReutersWorld stocks set for worst week since 2008 as virus fears grip marketsReutersOil-rich Alberta sees lower budget deficit in 2020-21, bets on recovery in crude pricesReutersRichard Branson’s Wealth Falls to Earth as Virgin Galactic SputtersBloombergA drug shortage due to the coronavirus is a 'considerable risk:' Fmr. FDA deputy commissionerYahoo Finance VideoBiocontainment expert on coronavirus: There's no need for average people to panic yetYahoo FinanceAmid coronavirus, bitcoin has fallen 6% this week to below $8,800Yahoo FinanceEl-Erian: The Fed will cut rates in March, if not beforeYahoo Finance VideoKorea Cases Top 2,000; WHO Sees ‘Decisive’ Stage: Virus UpdateBloombergDon’t buy the stock dip yet, says Goldman as it warns coronavirus will wipe out earnings growth this yearMarketWatchStock market live updates: Dow drops 1190 points amid coronavirus fears, S&P 500 sees fastest correction in historyYahoo FinanceMost face masks won’t protect you from the coronavirusYahoo FinanceCoronavirus-induced stock selloff means IPO market is 'on holiday': veteran IPO analystYahoo FinanceMarket Watcher: Over six months we will see the markets higher Yahoo Finance VideoStock market live updates: Stock futures climb after historic rout; coronavirus fears persistYahoo Finance